PacBio to Acquire Apton Biosystems in Deal Up to $110 Million
August 2, 2023
PacBio entered into an agreement to acquire Apton Biosystems, a Bay Area company developing a high-throughput short-read sequencer based on advanced optics, image processing, and clustering/chemistry. PacBio plans to integrate its Sequencing by Binding (SBB) short-read chemistry into Apton’s high-throughput instrument to accelerate development and commercialize a differentiated short-read platform.
- Buyers
- PacBio
- Targets
- Apton Biosystems, Inc (Apton)
- Industry
- Biotechnology
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.